{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T17:41:21Z","timestamp":1761154881219},"reference-count":14,"publisher":"Oxford University Press (OUP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,12,1]]},"DOI":"10.1093\/jac\/dki393","type":"journal-article","created":{"date-parts":[[2005,11,10]],"date-time":"2005-11-10T01:33:25Z","timestamp":1131586405000},"page":"1144-1147","source":"Crossref","is-referenced-by-count":49,"title":["Rates of antifungal resistance among Spanish clinical isolates of Cryptococcus neoformans var. neoformans"],"prefix":"10.1093","volume":"56","author":[{"given":"Alexander","family":"Perkins","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicia","family":"Gomez-Lopez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilia","family":"Mellado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan L.","family":"Rodriguez-Tudela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Cuenca-Estrella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2005,11,9]]},"reference":[{"key":"key\n\t\t\t\t20171010171024_B1","doi-asserted-by":"crossref","unstructured":"Brandt ME, Pfaller MA, Hajjeh RA et al. Trends in antifungal drug susceptibility of Cryptococcus neoformans isolates in the United States: 1992 to 1994 and 1996 to 1998. Antimicrob Agents Chemother2001; 45: 3065\u20139.","DOI":"10.1128\/AAC.45.11.3065-3069.2001"},{"key":"key\n\t\t\t\t20171010171024_B2","doi-asserted-by":"crossref","unstructured":"Venkateswarlu K, Taylor M, Manning NJ et al. Fluconazole tolerance in clinical isolates of Cryptococcus neoformans. Antimicrob Agents Chemother199741: 748\u201351.","DOI":"10.1128\/AAC.41.4.748"},{"key":"key\n\t\t\t\t20171010171024_B3","doi-asserted-by":"crossref","unstructured":"Rodero L, Mellado E, Rodriguez AC et al. G484S amino acid substitution in lanosterol 14-alpha demethylase (ERG11) is related to fluconazole resistance in a recurrent Cryptococcus neoformans clinical isolate. Antimicrob Agents Chemother2003; 47: 3653\u20136.","DOI":"10.1128\/AAC.47.11.3653-3656.2003"},{"key":"key\n\t\t\t\t20171010171024_B4","doi-asserted-by":"crossref","unstructured":"Pfaller MA, Messer SA, Boyken L et al. Global trends in the antifungal susceptibility of Cryptococcus neoformans (1990 to 2004). J Clin Microbiol2005; 43: 2163\u20137.","DOI":"10.1128\/JCM.43.5.2163-2167.2005"},{"key":"key\n\t\t\t\t20171010171024_B5","doi-asserted-by":"crossref","unstructured":"Sar B, Monchy D, Vann M et al. Increasing in vitro resistance to fluconazole in Cryptococcus neoformans Cambodian isolates: April 2000 to March 2002. J Antimicrob Chemother2004; 54: 563\u20135.","DOI":"10.1093\/jac\/dkh361"},{"key":"key\n\t\t\t\t20171010171024_B6","doi-asserted-by":"crossref","unstructured":"Rodriguez-Tudela JL, Barchiesi F, Bille J et al. Method for the determination of minimum inhibitory concentration (MIC) by broth dilution of fermentative yeasts. Clin Microbiol Infect2003; 9: I\u2013VIII.","DOI":"10.1046\/j.1469-0691.2003.00789.x"},{"key":"key\n\t\t\t\t20171010171024_B7","unstructured":"National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved Standard M27-A2. NCCLS, Wayne, PA, USA, 2002."},{"key":"key\n\t\t\t\t20171010171024_B8","doi-asserted-by":"crossref","unstructured":"Rodriguez-Tudela JL, Cuenca-Estrella M, Rodero L et al. Influence of shaking on antifungal susceptibility testing of Cryptococcus neoformans: a comparison of the NCCLS standard M27A medium, buffered yeast nitrogen base, and RPMI-2% glucose. Antimicrob Agents Chemother2000; 44: 400\u20134.","DOI":"10.1128\/AAC.44.2.400-404.2000"},{"key":"key\n\t\t\t\t20171010171024_B9","doi-asserted-by":"crossref","unstructured":"Espinel-Ingroff A, Barchiesi F, Cuenca-Estrella M et al. International and multicenter comparison of EUCAST and CLSI M27-A2 broth microdilution methods for testing susceptibilities of Candida spp. to fluconazole, itraconazole, posaconazole, and voriconazole. J Clin Microbiol2005; 43: 3884\u20139.","DOI":"10.1128\/JCM.43.8.3884-3889.2005"},{"key":"key\n\t\t\t\t20171010171024_B10","doi-asserted-by":"crossref","unstructured":"Cuenca-Estrella M, Gomez-Lopez A, Mellado E et al. In vitro activities of ravuconazole and four other antifungal agents against fluconazole-resistant or -susceptible clinical yeast isolates. Antimicrob Agents Chemother200448: 3107\u201311.","DOI":"10.1128\/AAC.48.8.3107-3111.2004"},{"key":"key\n\t\t\t\t20171010171024_B11","doi-asserted-by":"crossref","unstructured":"Cuenca-Estrella M, Gomez-Lopez A, Mellado E et al. Correlation between the procedure for antifungal susceptibility testing for Candida spp. of the European Committee on Antibiotic Susceptibility Testing (EUCAST) and four commercial techniques. Clin Microbiol Infect2005; 11: 486\u201392.","DOI":"10.1111\/j.1469-0691.2005.01166.x"},{"key":"key\n\t\t\t\t20171010171024_B12","doi-asserted-by":"crossref","unstructured":"Odds FC, De Backer T, Dams G et al. Oxygen as limiting nutrient for growth of Cryptococcus neoformans. J Clin Microbiol1995; 33: 995\u20137.","DOI":"10.1128\/JCM.33.4.995-997.1995"},{"key":"key\n\t\t\t\t20171010171024_B13","doi-asserted-by":"crossref","unstructured":"Ghannoum MA, Ibrahim AS, Fu Y et al. Susceptibility testing of Cryptococcus neoformans: a microdilution technique. J Clin Microbiol1992; 30: 2881\u20136.","DOI":"10.1128\/JCM.30.11.2881-2886.1992"},{"key":"key\n\t\t\t\t20171010171024_B14","doi-asserted-by":"crossref","unstructured":"Jessup CJ, Pfaller MA, Messer SA et al. Fluconazole susceptibility testing of Cryptococcus neoformans: comparison of two broth microdilution methods and clinical correlates among isolates from Ugandan AIDS patients. J Clin Microbiol199836: 2874\u20136.","DOI":"10.1128\/JCM.36.10.2874-2876.1998"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/56\/6\/1144\/2259811\/dki393.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,10]],"date-time":"2020-04-10T19:32:22Z","timestamp":1586547142000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/jac\/article\/56\/6\/1144\/753043\/Rates-of-antifungal-resistance-among-Spanish"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11,9]]},"references-count":14,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2005,11,9]]},"published-print":{"date-parts":[[2005,12,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dki393","relation":{},"ISSN":["1460-2091","0305-7453"],"issn-type":[{"value":"1460-2091","type":"electronic"},{"value":"0305-7453","type":"print"}],"subject":[],"published-other":{"date-parts":[[2005,12]]},"published":{"date-parts":[[2005,11,9]]}}}